REGGENATIVE HEALTH LEADER MEDEZ GROUP RECEIVES TOP AWARD AT ASIA CORPORATE EXCELLENCE & SUSTAINABILITY AWARDS
BANGKOK, Nov 19, 2024 - Medeze Group Public Company Limited, a leading hematopoietic stem cell (HSC) and mesenchymal stem cell (MSC) bank in Thailand, has been honored with the Industry Champions of the Year Award at the 2024 Asia Corporate Excellence & Sustainability (ACES) Awards.
Medeze Group's CEO, Dr. Veerapol Khemarangsan, received the prestigious award alongside other industry giants during a ceremony in Bangkok. The award recognizes Medeze Group's commitment to scientific excellence, quality, and innovation in regenerative healthcare.
Since its inception in 2010 as Bangkok Stem Cell, Medeze Group has expanded from a focused stem cell storage provider to a transformative leader in regenerative healthcare. With a strong focus on HSC and MSC banking, the company has integrated cutting-edge technologies and rigorous quality standards into its operations to deliver advanced health solutions across Southeast Asia.
One of Medeze's key accomplishments is the development of a Natural Killer (NK) cell immunotherapy programme designed to support the body's natural immune defences against pathogens and cancer cells. This innovative approach underscores Medeze's commitment to addressing the growing global demand for health solutions that combat chronic illnesses and cancer.
Medeze Group operates Southeast Asia's largest, state-of-the-art stem cell laboratories, equipped with NEBB-certified Class 10 Cleanrooms and adhering to American Association of Blood Banks (AABB) standards. The company has also pioneered adipose tissue storage service, providing future versatile stem cell solutions for treating conditions such as heart disease, diabetes, and neurodegenerative disorders.
Medeze Group's commitment to public education and community health improvement is also noteworthy. In 2015, the company founded the Bangkok Stem Cell Foundation to advance stem cell therapy awareness and accessibility, supporting public health through education, research, and community outreach.
"We are thrilled to receive this prestigious award from MORS Group," said Dr. Veerapol Khemarangsan. "This recognition is a testament to our team's dedication to delivering innovative and high-quality healthcare solutions that address the needs of our patients and communities."
As healthcare in Asia-Pacific evolves, Medeze Group remains well-positioned as a leader in regenerative medicine, offering a gold standard of healthcare excellence.
About Medeze Group Public Company Limited Medeze Group is a leading stem cell banking company in Thailand, dedicated to advancing preventive and longevity-focused healthcare across Southeast Asia and beyond. Visit https://www.medezegroup.com for more information.